- Home
- BMHL vs NRXS Comparison
BMHL vs NRXS Comparison
Compare BMHL & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BMHL | NRXS |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | Hong Kong | United States |
| Employees | 9 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.9M | 78.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | BMHL | NRXS |
|---|---|---|
| Price | $3.33 | $6.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 1.6K | ★ 227.3K |
| Earning Date | 08-14-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | N/A | $142.91 |
| Revenue Next Year | N/A | $120.00 |
| P/E Ratio | $66.66 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $2.72 | $1.33 |
| 52 Week High | $4.48 | $7.97 |
Technical Indicators
Market Signals| Indicator | BMHL | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 46.53 | 55.82 |
| Support Level | $3.32 | $5.77 |
| Resistance Level | $3.89 | $7.97 |
| Average True Range (ATR) | 0.16 | 0.69 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 50.00 | 43.59 |
Price Performance
Historical ComparisonAbout BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).